Literature DB >> 34249449

A novel CT-based radiomic nomogram for predicting the recurrence and metastasis of gastric stromal tumors.

Weiqun Ao1, Guohua Cheng2, Bin Lin3, Rong Yang4, Xuebin Liu4, Sheng Zhou5, Wenqi Wang5, Zhaoxing Fang2, Fengjuan Tian6, Guangzhao Yang1, Jian Wang1.   

Abstract

Our study aimed to explore the value of applying the CT-based radiomic nomogram for predicting recurrence and/or metastasis (RM) of gastric stromal tumors (GSTs). During the past ten years, a total of 236 patients with GST were analyzed retrospectively. According to the postoperative follow-up classification, the patients were divided into two groups, namely non-recurrence/metastasis group (non-RM) and RM group. All the cases were randomly divided into primary cohort and validation cohort according to the ratio of 7:3. Standardized CT images were segmented by radiologists using ITK-SNAP software manually. Texture features were extracted from all segmented lesions, then radiomic features were selected and the radiomic nomogram was built using least absolute shrinkage and selection operator (LASSO) method. The clinical features with the greatest correlation with RM of GST were selected by univariate analysis, and used as parameters to build the clinical feature model. Eventually, model of radiomic and clinical features were fitted to construct the clinical + radiomic feature model. The performance of each model was evaluated by the area under receiver operating characteristic (ROC) curve (AUC). A total of 1223 features were extracted from all the segmentation regions of each case, and features were selected via the least absolute shrinkage and LASSO binary logistic regression model. After deletion of redundant features, four key features were obtained, which were used as the parameters to build a radiomic signature. The AUCs of radiomic nomogram in primary cohort and validation cohort were 0.816 and 0.946, respectively. The AUCs of clinical + radiomic feature model in primary cohort and validation cohort were 0.833 and 0.937, respectively. Using DeLong test, the differences of AUC values between radiomic nomogram and clinical + radiomic feature model in primary cohort (P = 0.840) and validation cohort (P = 0.857) were not statistically significant. To sum up, CT-based radiomic nomogram is of great potential in predicting the RM of GST non-invasively before operation. AJCR
Copyright © 2021.

Entities:  

Keywords:  Computed tomography; gastric stromal tumors; metastasis; radiomics; recurrence

Year:  2021        PMID: 34249449      PMCID: PMC8263673     

Source DB:  PubMed          Journal:  Am J Cancer Res        ISSN: 2156-6976            Impact factor:   6.166


  26 in total

Review 1.  Getting the GIST: a pictorial review of the various patterns of presentation of gastrointestinal stromal tumors on imaging.

Authors:  Dominic Scola; Lawrence Bahoura; Alexander Copelan; Ali Shirkhoda; Farnoosh Sokhandon
Journal:  Abdom Radiol (NY)       Date:  2017-05

2.  Radiomic analysis of contrast-enhanced CT predicts microvascular invasion and outcome in hepatocellular carcinoma.

Authors:  Xun Xu; Hai-Long Zhang; Qiu-Ping Liu; Shu-Wen Sun; Jing Zhang; Fei-Peng Zhu; Guang Yang; Xu Yan; Yu-Dong Zhang; Xi-Sheng Liu
Journal:  J Hepatol       Date:  2019-03-13       Impact factor: 25.083

3.  Computed tomography-based radiomics model for discriminating the risk stratification of gastrointestinal stromal tumors.

Authors:  Lijing Zhang; Liqing Kang; Guoce Li; Xin Zhang; Jialiang Ren; Zhongqiang Shi; Jiayue Li; Shujing Yu
Journal:  Radiol Med       Date:  2020-02-11       Impact factor: 3.469

4.  Gastrointestinal stromal tumors (GIST): a proposal of a "CT-based predictive model of Miettinen index" in predicting the risk of malignancy.

Authors:  M A Mazzei; N Cioffi Squitieri; C Vindigni; S Guerrini; F Gentili; G Sadotti; P Mercuri; L Righi; G Lucii; F G Mazzei; D Marrelli; L Volterrani
Journal:  Abdom Radiol (NY)       Date:  2020-10

Review 5.  Imaging biomarker roadmap for cancer studies.

Authors:  James P B O'Connor; Eric O Aboagye; Judith E Adams; Hugo J W L Aerts; Sally F Barrington; Ambros J Beer; Ronald Boellaard; Sarah E Bohndiek; Michael Brady; Gina Brown; David L Buckley; Thomas L Chenevert; Laurence P Clarke; Sandra Collette; Gary J Cook; Nandita M deSouza; John C Dickson; Caroline Dive; Jeffrey L Evelhoch; Corinne Faivre-Finn; Ferdia A Gallagher; Fiona J Gilbert; Robert J Gillies; Vicky Goh; John R Griffiths; Ashley M Groves; Steve Halligan; Adrian L Harris; David J Hawkes; Otto S Hoekstra; Erich P Huang; Brian F Hutton; Edward F Jackson; Gordon C Jayson; Andrew Jones; Dow-Mu Koh; Denis Lacombe; Philippe Lambin; Nathalie Lassau; Martin O Leach; Ting-Yim Lee; Edward L Leen; Jason S Lewis; Yan Liu; Mark F Lythgoe; Prakash Manoharan; Ross J Maxwell; Kenneth A Miles; Bruno Morgan; Steve Morris; Tony Ng; Anwar R Padhani; Geoff J M Parker; Mike Partridge; Arvind P Pathak; Andrew C Peet; Shonit Punwani; Andrew R Reynolds; Simon P Robinson; Lalitha K Shankar; Ricky A Sharma; Dmitry Soloviev; Sigrid Stroobants; Daniel C Sullivan; Stuart A Taylor; Paul S Tofts; Gillian M Tozer; Marcel van Herk; Simon Walker-Samuel; James Wason; Kaye J Williams; Paul Workman; Thomas E Yankeelov; Kevin M Brindle; Lisa M McShane; Alan Jackson; John C Waterton
Journal:  Nat Rev Clin Oncol       Date:  2016-10-11       Impact factor: 66.675

6.  Building CT Radiomics-Based Models for Preoperatively Predicting Malignant Potential and Mitotic Count of Gastrointestinal Stromal Tumors.

Authors:  Chao Wang; Hailin Li; Yeerfan Jiaerken; Peiyu Huang; Lifeng Sun; Fei Dong; Yajing Huang; Di Dong; Jie Tian; Minming Zhang
Journal:  Transl Oncol       Date:  2019-07-04       Impact factor: 4.243

7.  Intratumoral and Peritumoral Radiomics of Contrast-Enhanced CT for Prediction of Disease-Free Survival and Chemotherapy Response in Stage II/III Gastric Cancer.

Authors:  Junmeng Li; Chao Zhang; Jia Wei; Peiming Zheng; Hui Zhang; Yi Xie; Junwei Bai; Zhonglin Zhu; Kangneng Zhou; Xiaokun Liang; Yaoqin Xie; Tao Qin
Journal:  Front Oncol       Date:  2020-12-04       Impact factor: 6.244

Review 8.  New advances in radiomics of gastrointestinal stromal tumors.

Authors:  Roberto Cannella; Ludovico La Grutta; Massimo Midiri; Tommaso Vincenzo Bartolotta
Journal:  World J Gastroenterol       Date:  2020-08-28       Impact factor: 5.742

Review 9.  Imaging therapy response of gastrointestinal stromal tumors (GIST) with FDG PET, CT and MRI: a systematic review.

Authors:  Antonia Dimitrakopoulou-Strauss; Ulrich Ronellenfitsch; Caixia Cheng; Leyun Pan; Christos Sachpekidis; Peter Hohenberger; Thomas Henzler
Journal:  Clin Transl Imaging       Date:  2017-05-03
View more
  2 in total

1.  Clinical parameters combined with radiomics features of PET/CT can predict recurrence in patients with high-risk pediatric neuroblastoma.

Authors:  Lijuan Feng; Luodan Qian; Shen Yang; Qinghua Ren; Shuxin Zhang; Hong Qin; Wei Wang; Chao Wang; Hui Zhang; Jigang Yang
Journal:  BMC Med Imaging       Date:  2022-05-28       Impact factor: 2.795

2.  CT-based radiomic nomogram for predicting the severity of patients with COVID-19.

Authors:  Hengfeng Shi; Zhihua Xu; Weiqun Ao; Jian Wang; Guohua Cheng; Hongli Ji; Linyang He; Juan Zhu; Hanjin Hu; Zongyu Xie
Journal:  Eur J Med Res       Date:  2022-01-25       Impact factor: 2.175

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.